TailorMed secures majority investment from GrowthCurve Capital to accelerate AI-powered medication access platform.
Round Type
Venture
New YorkSoftwareHealth CareInvestors
Description
TailorMed, a leading platform for medication access, affordability, and adherence solutions, announced a majority investment from GrowthCurve Capital, a New York-based private equity firm. The investment will support TailorMed's continued growth and expansion of its AI-powered solutions for providers, pharmacies, and patients. GrowthCurve's expertise in scaling data-driven businesses will enable TailorMed to expand its reach across its network of medication success resources. TailorMed operates the country's largest network of resources helping patients secure coverage, financial assistance, and support programs.
Quick answer
TailorMed raised an undisclosed amount in a funding round, dated November 2, 2026. Investors: GrowthCurve Capital. TailorMed is based in New York, New York, United States.
- How much did TailorMed raise?
- TailorMed raised an undisclosed amount in a funding round on November 2, 2026.
- Who invested in TailorMed?
- GrowthCurve Capital is named as investors in this round.
- What does TailorMed do?
- TailorMed is a health care technology company founded to help patients and health care organizations remove financial barriers to care by making it easier for patients to cover the cost of treatment.
- Where is TailorMed based and how big is it?
- TailorMed is based in New York, New York, United States.
- Who are the decision-makers at TailorMed?
- Fundz holds 1 contact at TailorMed. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Software and Health Care around the same time
Companies in the same sectors as TailorMed that raised within 45 days of this round, from Fundz verified event records.
- MyoWorks raised an undisclosed amount on November 10, 2026.
- Laza Medical raised $160M (Series B) on November 4, 2026.
- ClarityCare raised $16M (Series A) on October 27, 2026.
- Ambiki raised an undisclosed amount on October 23, 2026.
- Promaxo raised $100M (Series C) on October 22, 2026.
- Pennant raised $5M (Seed) on October 20, 2026.
Who to call at TailorMed, and when
A new round usually means TailorMed is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day TailorMed raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TailorMed, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TailorMed. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TailorMed raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
TailorMed raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.